HBM Holdings Ltd.

03/11/2021 | Press release | Distributed by Public on 03/11/2021 02:36

VOLUNTARY ANNOUNCEMENT - DOSING OF FIRST PATIENT IN TANFANERCEPT (HBM9036) PHASE III CLINICAL TRIAL